基于PDCA循环的

doi:10.5246/jcps.2024.11.072

中国药学(英文版) ›› 2024, Vol. 33 ›› Issue (11): 1001-1011.DOI: 10.5246/jcps.2024.11.072

基于PDCA循环的"1+X"药学会诊模型的构建

胥甜甜^#, 宋小玲^#, 陈璿瑛^*(), 吕燕妮^*()

南昌大学第一附属医院药学部, 江西南昌 330004

收稿日期:2023-12-26 修回日期:2024-02-12 接受日期:2024-04-26 出版日期:2024-12-10 发布日期:2024-12-10
通讯作者: 陈璿瑛, 吕燕妮

Developing a "1 + X" pharmaceutical consultation model through the PDCA cycle

Tiantian Xu^#, Xiaoling Song^#, Xuanying Chen^*(), Yanni Lv^*()

Department of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang 330004, Jiangxi, China

Received:2023-12-26 Revised:2024-02-12 Accepted:2024-04-26 Online:2024-12-10 Published:2024-12-10
Contact: Xuanying Chen, Yanni Lv
About author:
^# Tiantian Xu and Xiaoling Song contributed equally to this work.
Supported by:
Jiangxi Provincial Hospital Pharmacy Special Research Fund Project (Grant No. 2024-ZXYJ02), Jiangxi Provincial Department of Education Project (Grant No. 200227).

摘要/Abstract

摘要：

为了提高工作效率和准确性, 我们构建了基于PDCA循环的"1+X"药学会诊模式。通过分析现状, 查找会诊效率低的原因, 从人员培训、会诊宣传、会诊流程优化等方面探索药学会诊模式, 形成以抗感染会诊为主, 向多专业扩展的"1+X" 模式。2022年共开展药学会诊5044例, 较2017年同比增长了50%以上, 其中普通会诊3007例, 扩大会诊96例, 覆盖神经外科、神经内科等10多个科室, 会诊建议的采纳率为89.2%, 会诊的有效率为76.4%。由此可见, 基于PDCA循环的"1+X"药学会诊模式为医疗机构的药学会诊提供了实践参考, 也为临床药师的培养提供了有益的方法。

关键词: PDCA循环法, 药师, 会诊, 工作模式

Abstract:

To improve the efficiency and precision of our pharmacy consultation services, we adopted a "1+X" model based on the PDCA (Plan-Do-Check-Act) cycle. In the initial analysis, we identified factors contributing to suboptimal consultation efficiency. Our approach included a thorough examination of our pharmacy consultation system, encompassing personnel training, consultation promotion, and the refinement of the consultation process. A standardized pharmacy consultation model was devised and continually refined, with a primary focus on infectious diseases. Subsequently, the model expanded to include various medical specialties, fostering multi-disciplinary participation. Since the implementation of the "1+X" pharmacy consultation model, spanning from 2017 to 2022, consultation numbers exhibited a consistent annual growth exceeding 50%. In 2022 alone, 5044 pharmaceutical consultations were conducted, encompassing 3007 standard consultations and 96 expanded consultations across diverse departments such as neurosurgery and neurology. The adoption rate of consultation recommendations reached 89.2%, while the effectiveness of consultation treatments stood at an impressive 76.4%. This success underscored the impact of the "1+X" pharmacy consultation model on enhancing consultation outcomes. Collectively, our model, rooted in the PDCA cycle, not only served as a practical blueprint for pharmacy consultation systems in medical institutions but also provided valuable insights and a robust framework for the professional development and training of clinical pharmacists.

Key words: PDCA cycle method, Cinical pharmacist, Parmacy consultation, Model

Supporting:

胥甜甜, 宋小玲, 陈璿瑛, 吕燕妮. 基于PDCA循环的"1+X"药学会诊模型的构建[J]. 中国药学(英文版), 2024, 33(11): 1001-1011.

Tiantian Xu, Xiaoling Song, Xuanying Chen, Yanni Lv. Developing a "1 + X" pharmaceutical consultation model through the PDCA cycle[J]. Journal of Chinese Pharmaceutical Sciences, 2024, 33(11): 1001-1011.

图/表 8

Figure 1. Fishbone diagram of influencing factors of low pharmacy consultation services in 2017.

Figure 2. Influencing factors of low pharmacy consultation services.

Figure 3. Solutions to improve the quantity and quality of pharmacy consultation.

Figure 4. Analysis of the purpose of the pharmacy consultation in 2022.

Figure 5. Distribution of pharmacy consultations in different clinical departments in 2022.

Figure 6. Flow chart of the standardized pharmacy consultation model.

Table 1. Distribution of various types of pharmacy consultations during 2018–2022.

Table 2. Distribution of pharmacy consultations in different clinical specialties in 2022.

参考文献 16

[1]	Health and Wellness Commission of the People’s Republic of China. Notice on Strengthening Pharmacy Management and Transforming the Pharmacy Service Model [EB/OL].
[2]	Peng, G.L.; Xing, X.F.; Jia, L.L.; Wang, Y.H.; Jin, G.L. Han, Y. Current status of pharmacy consultation work in tertiary general hospitals based on literature analysis. Chin. J. Clin. Pharm. 2019, 03, 223–226.
[3]	Zhang, Y.; Yuan, H.L.; Xiao, H.; Tang, Y.J.; Wang, L.Z.; Li, W; Xu, L.T. Construction and application of a quality evaluation system for pharmacy monitoring under the new version of hospital accreditation standards. Clin. Med. Res. Pract. 2022, 11, 92–96.
[4]	Zhang, J.X.; Qian, X.; Xiong, S.J.; Chen, Q.; Bai, X.; Fan, L.Y.; Gao, L.; Li, L.H.; Xie, J. Establishment of a template and evaluation system for clinical pharmacists’ anti-infective consultation opinions. Chin. J. Hospital Pharm. 2020, 06,708–713.
[5]	Zhou, P.X.; Dong, S.J.; Li, X.X.; Yan, Y.Y.; Cheng, Y.C.; Li, H.B.; Shi, W.L.; Xu, X.H.; Ying, Y.Q.; Yang, Y.H.; Wang, Z.T.; Liu, F. Construction of standardized pharmacy consultation model based on PDCA cycle method. Chin. J. hospital pharm. 2022, 20, 2177–2181.
[6]	Su, S.; Lu, Q.Y.; Yang, H.K.; Chen, J.; Liu, J. Application of PDCA cycle method to reduce the error rate of intravenous medication dispensing in a static dispensing cente. J. Pharm. Sci. 2022, 07, 158–160.
[7]	Zhu, L.S.; Ji, X.H.; Kong, M.; Dong, C.; Chang, Y.L.; Lin, M. Analysis of the quality improvement effect of PDCA cycle method for experimental drug management. China Pharm. Ind. 2022, 15, 16–20.
[8]	Wang, W.; Ling, J.; Ni, Z.Y.; Qi, H.X. Analysis of the effect of PDCA cycle method to promote the management of key monitored drugs. J. Pharm. Pract. 2022, 02, 180–183.
[9]	Lourtet-Hascoët, J.; Félicé, M.P.; Bicart-See, A.; Bouige, A.; Giordano, G.; Bonnet, E. Species and antimicrobial susceptibility testing of coagulase-negative staphylococci in periprosthetic joint infections. Epidemiol. Infect. 2018, 146, 1771–1776.
[10]	Gould, F.K.; Brindle, R.; Chadwick, P.R.; Fraise, A.P.; Hill, S.; Nathwani, D.; Ridgway, G.L.; Spry, M.J.; Warren, R.E. Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom. J. Antimicrob. Chemother. 2009, 63, 849–861.
[11]	Brown, N.M.; Brown, E.M.; Brown, N.M.; Goodman, A.L.; Horner, C.; Jenkins, A.; Brown, E.M.; Group, T.G.D. Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK. J. Antimicrob. Chemother. 2021, 76, 1377–1378.
[12]	Yang, Y.; Zhong, X.; Zhang, C.L.; Zuo, W.; Zou, Y.Z.; Du, L.P.; Yan, X.L.; Hu, Y.; Yang, R.J.; Zhang, B. Analysis and effect evaluation of clinical pharmacists’ participation in infectious disease consultation cases. China Pharm. Affair. 2021, 02, 184–190.
[13]	Lu, Y.Z. Pharmaceutical practice and value of pharmacists under the new medical reform situation. J. Chin. Pharm. Sci. 2018, 27, 630–636.
[14]	Chen, B.; Yang, Z.F.; Qiao, Y.; Wen, A.D. Retrospective analysis of clinical pharmacist consultation cases in a hospital from 2015 to 2016. China Pharm. 2018, 03, 457–460.
[15]	Su, D.; Xu, S.; Wang, J.P. The practice and analysis of clinical pharmacists participating in 358 cases of consultation. China Pharm. 2016, 27, 1571–1574.
[16]	Yuan, L.; Yang, Q.; Xu, X.P.; De, Y.T.; Li, H.G. A pharmacist-led intervention study to improve treatment adherence in patients with chronic obstructive pulmonary disease. J. Chin. Pharm. Sci. 2023, 32, 52.

基于PDCA循环的"1+X"药学会诊模型的构建

Developing a "1 + X" pharmaceutical consultation model through the PDCA cycle

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 8

参考文献 16

相关文章 12

编辑推荐

Metrics

本文评价

[1]	卢晓静, 贾雪冬, 司方莹, 杨晰, 张婉, 尹钊. 药师主导的老年患者干预研究: 一项文献计量学分析[J]. 中国药学(英文版), 2024, 33(8): 751-765.
[2]	袁叶, 杨珍珍, 于博, 杨秀岭. 1例合并附壁血栓的缺血性心肌病心衰患者的用药分析及药学服务[J]. 中国药学(英文版), 2024, 33(1): 63-68.
[3]	袁叶, 于博, 杨珍珍, 董维冲, 杨秀岭. 达格列净在血容量不足患者中的药学监护及文献分析[J]. 中国药学(英文版), 2022, 31(9): 718-722.
[4]	涂颖秋, 胥甜甜, 彭洪薇, 陈长仁, 赖鑫, 万青, 潘德城, 张洁. 药师主导的肠外营养处方审核策略的分析与改进[J]. 中国药学(英文版), 2022, 31(2): 142-152.
[5]	周毅, 吴星烨, 李娟, 程伟, 李小松, 沈依帆, 张军. 药师在胃肠间质瘤多学科诊疗团队中的作用[J]. 中国药学(英文版), 2021, 30(7): 598-605.
[6]	聂玉瑶, 王贺, 周林光, 史录文, 江滨. 中国药师对仿制药认知的调查研究[J]. 中国药学(英文版), 2020, 29(5): 364-368.
[7]	冯书云, 郭锦辉, 卢乙众. 新医改形势下药学服务与药师价值的探索[J]. 中国药学(英文版), 2018, 27(9): 630-636.
[8]	王利群, 谢晓慧, 周瑞瑞. 我国大陆期刊哮喘药学服务随机对照研究的质量评价[J]. 中国药学(英文版), 2017, 26(3): 212-221.
[9]	赵琪, 徐晓媛, 张洁菡. 我国药师胜任力模型构建研究[J]. 中国药学(英文版), 2016, 25(11): 846-854.
[10]	朱愿超, 胡永芳, 杨莉萍, 胡欣. 临床药师干预对甲状腺手术围术期预防应用抗菌药物的影响[J]. 中国药学(英文版), 2015, 24(9): 617-624.
[11]	张金莲, 周佳, 陈霁晖, 陈婷, 刘艳, 田怀平, 张健. 临床药师对婴幼儿万古霉素血药浓度监测情况分析[J]. 中国药学(英文版), 2015, 24(4): 263-266.
[12]	包宁疆, 邵宏^*, 聂小燕, 吴永佩, 颜青, 李喜西, 杨巍, 王宁, 郑凯, 魏艳红, 史录文. 我国临床药师培训试点情况调查与分析[J]. , 2011, 20(4): 410-414.